Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DMACDiaMedica Therapeutics Inc.

Nasdaq · CIK 0001401040
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts203

Identity from submissions API

NameDiaMedica Therapeutics Inc.
CIK0001401040
TickersDMAC
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationZ4 Canada (Federal Level)
Phone(763) 496-5454
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • DiaMedica Inc. (2007-05-16T04:00:00.000Z → 2014-03-11T04:00:00.000Z)
Business address
301 CARLSON PARKWAY
SUITE 210
MINNEAPOLIS
MN
55305
MN
Mailing address
301 CARLSON PARKWAY
SUITE 210
MINNEAPOLIS
MN
55305
MN

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

429 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q FORM 10-Q 0001437749-26-036602 001-36291 261547784 34 5510478 1 1
2026-11-12 8-K FORM 8-K 2.02,9.01 0001437749-26-036600 001-36291 261547766 34 443024 1 1
2026-08-12 4 xslF345X06/form4-08122026_080836.xml 0001760123-26-000004 5534
2026-08-11 S-8 FORM S-8 0001437749-26-026864 333-298210 261260786 33 225790 1 1
2026-08-10 10-Q FORM 10-Q 0001437749-26-026792 001-36291 261259055 34 5315724 1 1
2026-08-10 8-K FORM 8-K 2.02,9.01 0001437749-26-026790 001-36291 261259012 34 490201 1 1
2026-06-03 4 xslF345X06/form4-06032026_090625.xml 0001759822-26-000004 16129
2026-06-03 4 xslF345X06/form4-06032026_090653.xml 0001341125-26-000002 16089
2026-06-03 4 xslF345X06/form4-06032026_090622.xml 0001376847-26-000002 16334
2026-06-03 4 xslF345X06/form4-06032026_090650.xml 0001451038-26-000002 16081
2026-06-03 4 xslF345X06/form4-06032026_090620.xml 0001872863-26-000004 16121
2026-06-03 4 xslF345X06/form4-06032026_090621.xml 0001759855-26-000004 16111
2026-06-03 4 xslF345X06/form4-06032026_090640.xml 0001760123-26-000002 16245
2026-06-03 4 xslF345X06/form4-06032026_090610.xml 0001490476-26-000002 16225
2026-06-03 4 xslF345X06/form4-06032026_090627.xml 0001643127-26-000002 5703
2026-05-21 8-K FORM 8-K 5.07 0001437749-26-018106 001-36291 261009019 34 190778 1 1
2026-05-06 10-Q FORM 10-Q 0001437749-26-015220 001-36291 26949174 34 4476763 1 1
2026-05-06 8-K FORM 8-K 2.02,9.01 0001437749-26-015218 001-36291 26949153 34 371474 1 1
2026-04-01 ARS ARS 0001437749-26-010881 001-36291 26828218 34 11052029
2026-04-01 DEFA14A FORM DEFA14A 0001437749-26-010880 001-36291 26828201 34 517366
2026-04-01 DEF 14A FORM DEF 14A 0001437749-26-010879 001-36291 26828147 34 4095213 1 1
2026-03-31 8-K FORM 8-K 2.02,9.01 0001437749-26-010409 001-36291 26815790 34 375024 1 1
2026-03-30 10-K FORM 10-K 0001437749-26-010342 001-36291 26813594 34 10881107 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000945621-26-000352 005-90788 26640657 34 7088
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000919574-26-001133 005-90788 26639392 34 22738
2026-02-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-011569 005-90788 26608209 34 9664
2026-01-06 4 xslF345X05/form4-01062026_100130.xml 0001759855-26-000002 5139
2026-01-06 4 xslF345X05/form4-01062026_100105.xml 0001759822-26-000002 6729
2026-01-06 4 xslF345X05/form4-01062026_100121.xml 0001872863-26-000002 5158
2026-01-05 8-K FORM 8-K 8.01 0001437749-26-000175 001-36291 26504115 34 149394 1 1
2025-12-18 8-K FORM 8-K 7.01,8.01,9.01 0001437749-25-038211 001-36291 251581410 34 189024 1 1
2025-12-08 4 OWNERSHIP DOCUMENT 0001104659-25-119360 16628
2025-11-25 4 xslF345X05/form4-11252025_091152.xml 0001759855-25-000006 7068
2025-11-13 S-8 FORM S-8 0001437749-25-034866 333-291508 251479119 33 203796 1 1
2025-11-12 10-Q FORM 10-Q 0001437749-25-034469 001-36291 251473512 34 5488809 1 1
2025-11-12 8-K FORM 8-K 2.02,9.01 0001437749-25-034467 001-36291 251473480 34 399834 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-272616 005-90788 251463746 34 7231
2025-11-03 4 xslF345X05/form4-11032025_091158.xml 0001643127-25-000006 5815
2025-11-03 3 xslF345X02/form3-11032025_091120.xml 0001643127-25-000005 13528
2025-10-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000945621-25-000973 005-90788 251395400 34 7082
2025-09-04 4 OWNERSHIP DOCUMENT 0001104659-25-087410 19912
2025-09-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-087405 005-90788 251292781 34 9735
2025-08-27 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000945621-25-000820 005-90788 251265559 34 6998
2025-08-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002724 333-289542 251247803 33 1861
2025-08-22 424B2 FORM 424B2 0001437749-25-027557 333-289542 251242454 33 282594
2025-08-20 CORRESP filename1.htm 0001437749-25-027408 17897
2025-08-18 UPLOAD filename1.pdf 0000000000-25-008689 333-289542 40198
2025-08-12 8-K FORM 8-K 1.01,9.01 0001437749-25-026286 001-36291 251208114 34 174056 1 1
2025-08-12 S-3 FORM S-3 0001437749-25-026273 333-289542 251207806 33 1114653 1 1
2025-08-12 10-Q FORM 10-Q 0001437749-25-026207 001-36291 251206961 34 5300241 1 1
2025-08-12 8-K FORM 8-K 2.02,9.01 0001437749-25-026205 001-36291 251206899 34 407179 1 1
2025-08-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002540 333-289159 251199963 33 1861
2025-08-06 CORRESP filename1.htm 0001437749-25-024968 19751
2025-08-06 8-K FORM 8-K 5.02,7.01,8.01,9.01 0001437749-25-024956 001-36291 251187541 34 255272 1 1
2025-08-05 UPLOAD filename1.pdf 0000000000-25-008250 333-289159 40214
2025-08-01 S-3 FORM S-3 0001437749-25-024290 333-289159 251174035 33 751888 1 1
2025-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-072279 005-90788 251168341 34 9946
2025-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-072272 005-90788 251168338 34 11535
2025-07-25 4 OWNERSHIP DOCUMENT 0001104659-25-070920 6742
2025-07-25 4 OWNERSHIP DOCUMENT 0001104659-25-070900 8582
2025-07-25 4 FORM 4 0001437749-25-023532 4684
2025-07-25 D xslFormDX01/primary_doc.xml 06b 0001437749-25-023439 021-552749 251148026 33 13430
2025-07-21 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-25-023048 001-36291 251135745 34 629250 1 1
2025-07-17 8-K FORM 8-K 7.01,9.01 0001437749-25-022877 001-36291 251128860 34 2733823 1 1
2025-06-03 4 FORM 4 0001437749-25-019296 5938
2025-06-03 4 FORM 4 0001437749-25-019295 5986
2025-06-03 4 FORM 4 0001437749-25-019294 6215
2025-06-03 4 FORM 4 0001437749-25-019293 6145
2025-06-03 4 FORM 4 0001437749-25-019292 5712
2025-06-03 4 FORM 4 0001437749-25-019291 5970
2025-06-03 4 FORM 4 0001437749-25-019290 5908
2025-06-03 4 FORM 4 0001437749-25-019289 7930
2025-05-15 8-K FORM 8-K 5.07,9.01 0001437749-25-017239 001-36291 25954658 34 190673 1 1
2025-05-13 10-Q FORM 10-Q 0001437749-25-016488 001-36291 25940682 34 4394027 1 1
2025-05-13 8-K FORM 8-K 2.02,9.01 0001437749-25-016487 001-36291 25940653 34 380276 1 1
2025-04-08 4 PRIMARY DOCUMENT 0001760016-25-000004 7596
2025-03-28 ARS ARS 0001437749-25-009703 001-36291 25781499 34 6060527
2025-03-28 DEFA14A FORM DEFA14A 0001437749-25-009698 001-36291 25781464 34 586686
2025-03-28 DEF 14A FORM DEF 14A 0001437749-25-009696 001-36291 25781460 34 3230485 1 1
2025-03-17 10-K FORM 10-K 0001437749-25-008018 001-36291 25745020 34 8172727 1 1
2025-03-17 8-K FORM 8-K 2.02,9.01 0001437749-25-008014 001-36291 25744958 34 380326 1 1
2025-03-06 8-K FORM 8-K 5.02 0001437749-25-006379 001-36291 25713701 34 155789 1 1
2025-02-24 4 PRIMARY DOCUMENT 0001235802-25-000012 6144
2025-02-24 3 PRIMARY DOCUMENT 0001235802-25-000011 10679
2025-02-24 8-K FORM 8-K 5.02,7.01,9.01 0001437749-25-004891 001-36291 25657490 34 300516 1 1
2025-02-18 4 PRIMARY DOCUMENT 0001235802-25-000009 12701
2025-01-03 4 PRIMARY DOCUMENT 0001235802-25-000005 7802
2025-01-03 4 PRIMARY DOCUMENT 0001235802-25-000004 7299
2025-01-03 4 PRIMARY DOCUMENT 0001235802-25-000003 5382
2025-01-03 4 PRIMARY DOCUMENT 0001235802-25-000002 5505
2025-01-03 4 PRIMARY DOCUMENT 0001235802-25-000001 5371
2024-11-13 10-Q FORM 10-Q 0001437749-24-034925 001-36291 241454666 34 5006002 1 1
2024-11-13 8-K FORM 8-K 2.02,7.01,9.01 0001437749-24-034922 001-36291 241454638 34 1038100 1 1
2024-08-07 8-K FORM 8-K 2.02,9.01 0001437749-24-025200 001-36291 241184357 34 401632 1 1
2024-08-07 10-Q FORM 10-Q 0001437749-24-025198 001-36291 241184330 34 4264697 1 1
2024-07-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-18 17:00:00 9999999995-24-002200 333-280744 241125964 33 1868
2024-07-18 424B3 FORM 424B3 0001437749-24-023005 333-280744 241125552 33 426348
2024-07-16 CORRESP filename1.htm 0001437749-24-022765 18077
2024-07-15 UPLOAD filename1.pdf 0000000000-24-007997 333-280744 40144
2024-07-10 S-3 FORM S-3 0001437749-24-022469 333-280744 241110140 33 664381
2024-07-08 SC 13G d11408321_13-g.htm 0000919574-24-003946 005-90788 241105828 34 140903
2024-07-02 D xslFormDX01/primary_doc.xml 06b 0001235802-24-000055 021-517673 241095182 33 13247
2024-07-02 144 xsl144X01/primary_doc.xml 0001945603-24-000001 001-36291 241094351 33 4443
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076844 8608
2024-07-01 4 OWNERSHIP DOCUMENT 0001104659-24-076840 6750
2024-06-26 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-24-021220 001-36291 241070681 34 625589 1 1
2024-06-26 8-K FORM 8-K 7.01,8.01,9.01 0001437749-24-021219 001-36291 241070652 34 3375325 1 1
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000053 6214
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000052 6213
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000051 6214
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000050 6461
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000049 6252
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000048 6404
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000047 6403
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000046 5996
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000045 6264
2024-06-03 4 PRIMARY DOCUMENT 0001235802-24-000044 8197
2024-05-24 S-8 FORM S-8 0001437749-24-018319 333-279710 24984133 33 120516
2024-05-23 8-K FORM 8-K 5.02,5.07,9.01 0001437749-24-018140 001-36291 24977990 34 466432 1 1
2024-05-08 10-Q FORM 10-Q 0001437749-24-015381 001-36291 24926798 34 3858276 1 1
2024-05-08 8-K FORM 8-K 2.02,9.01 0001437749-24-015378 001-36291 24926708 34 377917 1 1
2024-04-10 8-K FORM 8-K 5.02 0001437749-24-011645 001-36291 24836248 34 149204 1 1
2024-04-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-09 09:00:00 9999999995-24-000904 333-278146 24834109 33 1867
2024-04-04 CORRESP filename1.htm 0001437749-24-011067 15309
2024-04-04 ARS ARS 0001437749-24-010992 001-36291 24821558 34 3085600
2024-04-04 DEFA14A FORM DEFA14A 0001437749-24-010987 001-36291 24821549 34 309438
2024-04-04 DEF 14A FORM DEF 14A 0001437749-24-010985 001-36291 24821542 34 1760488
2024-03-26 UPLOAD filename1.pdf 0000000000-24-003272 333-278146 40451
2024-03-21 S-3 FORM S-3 0001437749-24-008868 333-278146 24772009 33 527738
2024-03-19 10-K FORM 10-K 0001437749-24-008522 001-36291 24763473 34 7170141 1 1
2024-03-19 8-K FORM 8-K 2.02,9.01 0001437749-24-008521 001-36291 24763444 34 386200 1 1
2024-01-23 4 PRIMARY DOCUMENT 0001235802-24-000015 6240
2024-01-23 3 PRIMARY DOCUMENT 0001235802-24-000014 6921
2024-01-02 4 PRIMARY DOCUMENT 0001235802-24-000005 5313
2024-01-02 4 PRIMARY DOCUMENT 0001235802-24-000004 5138
2024-01-02 4 PRIMARY DOCUMENT 0001235802-24-000003 5299
2024-01-02 4 PRIMARY DOCUMENT 0001235802-24-000002 5295
2024-01-02 4 PRIMARY DOCUMENT 0001235802-24-000001 7092
2023-11-16 4 PRIMARY DOCUMENT 0001235802-23-000111 5195
2023-11-13 10-Q FORM 10-Q 0001437749-23-031671 001-36291 231399757 34 4151070 1 1
2023-11-13 8-K FORM 8-K 2.02,7.01,9.01 0001437749-23-031669 001-36291 231399729 34 867159 1 1
2023-09-05 8-K FORM 8-K 5.02,9.01 0001437749-23-025203 001-36291 231235948 34 328956 1 1
2023-08-14 10-Q FORM 10-Q 0001437749-23-023708 001-36291 231170866 34 4086581 1 1
2023-08-14 8-K FORM 8-K 2.02,9.01 0001437749-23-023698 001-36291 231170759 34 354715 1 1
2023-07-10 424B3 FORM 424B3 0001437749-23-019651 333-273068 231079918 33 481535
2023-07-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-07-07 17:00:00 9999999995-23-002034 333-273068 231078122 33 1819
2023-07-05 CORRESP filename1.htm 0001437749-23-019338 16088
2023-07-05 UPLOAD filename1.pdf 0000000000-23-007072 40356
2023-06-30 S-3 FORM S-3 0001437749-23-019036 333-273068 231061947 33 742360
2023-06-27 SC 13G/A SC 13G/A 0001104659-23-075254 005-90788 231047410 34 63655
2023-06-27 D xslFormDX01/primary_doc.xml 06b 0001235802-23-000074 021-485302 231047408 33 16185
2023-06-27 SC 13G/A SC 13G/A 0001104659-23-075251 005-90788 231047404 34 53818
2023-06-27 4 OWNERSHIP DOCUMENT 0001104659-23-075250 8360
2023-06-27 3 OWNERSHIP DOCUMENT 0001104659-23-075248 5680
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000073 8224
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000072 4854
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000071 4783
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000070 4572
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000069 4574
2023-06-26 4 PRIMARY DOCUMENT 0001235802-23-000068 4933
2023-06-23 SC 13G/A SC 13G/A 0001193125-23-173961 005-90788 231038657 34 44119
2023-06-23 3 3 0000950170-23-029676 3909
2023-06-21 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-23-017922 001-36291 231027468 34 637344 1 1
2023-06-21 8-K FORM 8-K 7.01,9.01 0001437749-23-017917 001-36291 231027447 34 7371869 1 1
2023-06-21 8-K FORM 8-K 8.01,9.01 0001437749-23-017914 001-36291 231027440 34 207636 1 1
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000065 6143
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000064 6132
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000063 6122
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000062 6128
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000061 6379
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000060 6144
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000059 6294
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000058 6291
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000057 5911
2023-06-02 4 PRIMARY DOCUMENT 0001235802-23-000056 8087
2023-05-30 4 PRIMARY DOCUMENT 0001790300-23-000003 5919
2023-05-30 3 PRIMARY DOCUMENT 0001790300-23-000002 6801
2023-05-30 8-K FORM 8-K 5.02,7.01,9.01 0001437749-23-016029 001-36291 23971567 34 209761 1 1
2023-05-22 8-K FORM 8-K 7.01,8.01,9.01 0001437749-23-015488 001-36291 23945394 34 1149974 1 1
2023-05-18 8-K FORM 8-K 5.03,5.07,9.01 0001437749-23-015120 001-36291 23936526 34 667051 1 1
2023-05-15 10-Q FORM 10-Q 0001437749-23-014616 001-36291 23923236 34 3921114 1 1
2023-05-15 8-K FORM 8-K 2.02,9.01 0001437749-23-014610 001-36291 23923159 34 329484 1 1
2023-04-18 D xslFormDX01/primary_doc.xml 06b 0001235802-23-000041 021-479300 23827209 33 13155
2023-04-11 4 PRIMARY DOCUMENT 0001235802-23-000040 7067
2023-04-11 3 PRIMARY DOCUMENT 0001235802-23-000039 6598
2023-04-04 ARS formars.pdf 0001437749-23-009172 001-36291 23795086 34 4461116
2023-04-04 DEFA14A FORM DEFA14A 0001437749-23-009170 001-36291 23795078 34 619264
2023-04-04 DEF 14A FORM DEF 14A 0001437749-23-009169 001-36291 23795076 34 1470353
2023-03-28 10-K FORM 10-K 0001437749-23-008189 001-36291 23770013 34 6807123 1 1
2023-03-28 8-K FORM 8-K 2.02,9.01 0001437749-23-008188 001-36291 23769982 34 335733 1 1
2023-03-17 PRE 14A FORM PRE 14A 0001437749-23-006959 001-36291 23740650 34 1470714
2023-03-10 8-K FORM 8-K 7.01 0001437749-23-006195 001-36291 23724313 34 158449 1 1
2023-03-10 8-K/A FORM 8-K/A 5.02 0001437749-23-006083 001-36291 23721665 34 162702 1 1
2023-03-06 4 PRIMARY DOCUMENT 0001235802-23-000029 5880
2023-03-06 3 PRIMARY DOCUMENT 0001235802-23-000028 7190
2023-03-06 8-K FORM 8-K 5.02,7.01,9.01 0001437749-23-005471 001-36291 23707660 34 194103 1 1
2023-02-13 SC 13G/A dmac13ga.htm 0000935836-23-000141 005-90788 23615518 34 36444
2023-01-13 SC 13G/A SC 13G/A 0001193125-23-008431 005-90788 23529273 34 45391
2023-01-03 4 PRIMARY DOCUMENT 0001235802-23-000004 6975
2023-01-03 4 PRIMARY DOCUMENT 0001235802-23-000003 5018
2023-01-03 4 PRIMARY DOCUMENT 0001235802-23-000002 5010
2023-01-03 4 PRIMARY DOCUMENT 0001235802-23-000001 5182
2022-12-12 4 PRIMARY DOCUMENT 0001235802-22-000135 8820
2022-12-08 4 PRIMARY DOCUMENT 0001235802-22-000134 8819
2022-12-06 SC 13G/A SCHEDULE 13G 0000910680-22-000009 005-90788 221447703 34 52743
2022-12-06 4 FORM 4 0001567619-22-021344 10109
2022-12-05 4 PRIMARY DOCUMENT 0001235802-22-000130 5491
2022-12-05 4 PRIMARY DOCUMENT 0001235802-22-000129 6910
2022-12-01 4 PRIMARY DOCUMENT 0001235802-22-000128 11710
2022-11-16 4 PRIMARY DOCUMENT 0001235802-22-000121 5406
2022-11-09 10-Q FORM 10-Q 0001437749-22-026609 001-36291 221372966 34 3926474 1 1
2022-11-09 8-K FORM 8-K 2.02,9.01 0001437749-22-026608 001-36291 221372947 34 370621 1 1
2022-10-26 8-K FORM 8-K 2.02,8.01,9.01 0001437749-22-024801 001-36291 221333567 34 226838 1 1
2022-09-15 4 PRIMARY DOCUMENT 0001235802-22-000111 6134
2022-09-15 3 PRIMARY DOCUMENT 0001235802-22-000110 7282
2022-08-11 S-8 dmtp20220809_s8.htm 0001437749-22-020160 333-266789 221156503 33 129865
2022-08-11 10-Q FORM 10-Q 0001437749-22-019848 001-36291 221152917 34 3877301 1 1
2022-08-10 8-K FORM 8-K 2.02,9.01 0001437749-22-019840 001-36291 221152822 34 374828 1 1
2022-07-21 4 FORM 4 0001567619-22-014290 7163
2022-07-21 3 FORM 3 0001567619-22-014288 5728
2022-07-12 SC 13G/A SCHEDULE 13G 0000910680-22-000005 005-90788 221078822 34 46424
2022-07-06 8-K FORM 8-K 8.01,9.01 0001437749-22-016730 001-36291 221069122 34 211210 1 1
2022-06-29 8-K FORM 8-K 1.01,9.01 0001437749-22-016176 001-36291 221055006 34 1412879 1 1
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000076 6341
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000075 6103
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000074 6095
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000073 8758
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000072 6252
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000071 6255
2022-06-02 4 PRIMARY DOCUMENT 0001235802-22-000070 5875
2022-05-27 SC 13G SC 13G 0001193125-22-162432 005-90788 22978463 34 45509
2022-05-25 8-K FORM 8-K 5.02,9.01 0001437749-22-013555 001-36291 22963779 34 312569 1 1
2022-05-19 8-K FORM 8-K 5.02,5.07,9.01 0001437749-22-013082 001-36291 22943926 34 437295 1 1
2022-05-04 10-Q FORM 10-Q 0001437749-22-010876 001-36291 22892225 34 3533434 1 1
2022-05-04 8-K FORM 8-K 2.02,9.01 0001437749-22-010872 001-36291 22892182 34 328628 1 1
2022-04-05 DEFA14A FORM DEFA14A 0001437749-22-008266 001-36291 22805110 34 562817
2022-04-05 DEF 14A FORM DEF 14A 0001437749-22-008264 001-36291 22805100 34 1629425
2022-03-14 S-8 FORM S-8 0001437749-22-006171 333-263543 22737603 33 131954
2022-03-14 10-K FORM 10-K 0001437749-22-006163 001-36291 22737391 34 6916157 1 1
2022-03-14 8-K FORM 8-K 2.02,9.01 0001437749-22-006162 001-36291 22737356 34 346184 1 1
2022-02-15 SC 13G/A diamedica13ga.htm 0000935836-22-000193 005-90788 22638542 34 30886
2022-02-11 8-K FORM 8-K 8.01 0001437749-22-003142 001-36291 22621174 34 161260 1 1
2022-02-11 SC 13G/A diamedica13ga.htm 0000935836-22-000073 005-90788 22619348 34 60648
2022-02-02 4 PRIMARY DOCUMENT 0001235802-22-000024 8498
2022-02-02 3 PRIMARY DOCUMENT 0001235802-22-000023 7261
2022-01-05 4 PRIMARY DOCUMENT 0001235802-22-000013 6108
2022-01-05 3 PRIMARY DOCUMENT 0001235802-22-000012 6603
2022-01-03 4 PRIMARY DOCUMENT 0001235802-22-000004 5018
2022-01-03 4 PRIMARY DOCUMENT 0001235802-22-000003 5180
2022-01-03 4 PRIMARY DOCUMENT 0001235802-22-000002 5428
2022-01-03 4 PRIMARY DOCUMENT 0001235802-22-000001 7943
2021-12-22 CT ORDER filename1.pdf 20211222,20211222 9999999997-21-006005 333-228313 211510991 33 158958
2021-11-10 10-Q FORM 10-Q 0001437749-21-026175 001-36291 211397255 34 4000929 1 1
2021-11-10 8-K FORM 8-K 2.02,9.01 0001437749-21-026172 001-36291 211397230 34 364254 1 1
2021-10-15 424B3 FORM 424B3 0001437749-21-023710 333-260066 211324753 33 515362
2021-10-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-10-14 17:00:00 9999999995-21-003890 333-260066 211324682 33 1819
2021-10-12 CORRESP filename1.htm 0001437749-21-023542 20161
2021-10-12 UPLOAD filename1.pdf 0000000000-21-012338 40323
2021-10-08 SC 13G SCHEDULE 13G 0000910680-21-000067 005-90788 211315502 34 47211
2021-10-08 SC 13G SCHEDULE 13G 0000910680-21-000065 005-90788 211315457 34 46474
2021-10-06 SC 13G diamedicatherapeutics13g.htm 0000935836-21-000564 005-90788 211309963 34 31054
2021-10-06 D xslFormDX01/primary_doc.xml 06b 0001235802-21-000122 021-415804 211307924 33 12731
2021-10-05 S-3 FORM S-3 0001437749-21-023302 333-260066 211307537 33 637719
2021-09-27 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-21-022654 001-36291 211279074 34 666180 1 1
2021-09-15 4 PRIMARY DOCUMENT 0001235802-21-000119 5267
2021-09-13 8-K FORM 8-K 7.01,8.01,9.01 0001437749-21-022033 001-36291 211250028 34 1950582 1 1
2021-08-17 4 PRIMARY DOCUMENT 0001235802-21-000101 4474
2021-08-17 4 PRIMARY DOCUMENT 0001235802-21-000100 6442
2021-08-16 4 PRIMARY DOCUMENT 0001235802-21-000099 7670
2021-08-16 4 PRIMARY DOCUMENT 0001235802-21-000098 5401
2021-08-16 4 PRIMARY DOCUMENT 0001235802-21-000097 4535
2021-08-11 10-Q FORM 10-Q 0001437749-21-019480 001-36291 211163880 34 4028245 1 1
2021-08-11 8-K FORM 8-K 2.02,9.01 0001437749-21-019477 001-36291 211163839 34 197274
2021-07-29 4 PRIMARY DOCUMENT 0001235802-21-000094 5938
2021-07-29 4 PRIMARY DOCUMENT 0001235802-21-000093 5940
2021-07-29 4 PRIMARY DOCUMENT 0001235802-21-000092 6180
2021-07-29 4 PRIMARY DOCUMENT 0001235802-21-000091 5931
2021-07-16 4 PRIMARY DOCUMENT 0001235802-21-000082 8761
2021-07-16 4 PRIMARY DOCUMENT 0001235802-21-000081 6247
2021-07-16 4 PRIMARY DOCUMENT 0001235802-21-000080 6252
2021-07-16 4 PRIMARY DOCUMENT 0001235802-21-000079 5868
2021-07-16 3 PRIMARY DOCUMENT 0001235802-21-000078 6529
2021-07-16 4 PRIMARY DOCUMENT 0001235802-21-000077 5879
2021-07-16 3 PRIMARY DOCUMENT 0001235802-21-000076 6556
2021-07-16 8-K FORM 8-K 5.02,5.07 0001437749-21-017038 001-36291 211094315 34 47498
2021-06-29 8-K FORM 8-K 7.01,8.01,9.01 0001437749-21-015877 001-36291 211055557 34 13915627
2021-06-03 DEFA14A FORM DEFA14A 0001437749-21-014067 001-36291 21992681 34 681822
2021-06-03 DEF 14A FORM DEF 14A 0001437749-21-014066 001-36291 21992657 34 1262120
2021-05-05 10-Q FORM 10-Q 0001437749-21-010912 001-36291 21893911 34 3185387 1
2021-05-05 8-K FORM 8-K 2.02,9.01 0001437749-21-010911 001-36291 21893853 34 187696
2021-05-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-05-04 15:30:00 9999999995-21-001779 333-254089 21890987 33 1814
2021-05-03 CORRESP filename1.htm 0001437749-21-010532 20679
2021-04-29 10-K/A FORM 10-K/A 0001437749-21-010229 001-36291 21871276 34 683676
2021-04-29 8-K FORM 8-K 8.01 0001437749-21-010228 001-36291 21871242 34 26692
2021-03-11 UPLOAD filename1.pdf 0000000000-21-002959 40300
2021-03-10 S-3 FORM S-3 0001437749-21-005552 333-254089 21730237 33 424964
2021-03-10 10-K FORM 10-K 0001437749-21-005541 001-36291 21729675 34 6072056 1
2021-03-10 8-K FORM 8-K 2.02,9.01 0001437749-21-005540 001-36291 21729651 34 195419
2021-02-12 SC 13G/A dmac13ga.htm 0000935836-21-000121 005-90788 21629221 34 60007
2021-01-04 4 PRIMARY DOCUMENT 0001235802-21-000003 7686
2021-01-04 4 PRIMARY DOCUMENT 0001235802-21-000002 5172
2021-01-04 4 PRIMARY DOCUMENT 0001235802-21-000001 5174
2020-12-23 SC 13G/A SCHEDULE 13G/A 0001437749-20-025881 005-90788 201412749 34 88578
2020-12-04 4 PRIMARY DOCUMENT 0001790300-20-000011 6433
2020-11-23 4 PRIMARY DOCUMENT 0001235802-20-000138 7991
2020-11-10 4 PRIMARY DOCUMENT 0001235802-20-000122 5157
2020-11-04 10-Q FORM 10-Q 0001437749-20-022537 001-36291 201287156 34 3814959 1
2020-11-04 8-K FORM 8-K 2.02,9.01 0001437749-20-022536 001-36291 201287135 34 232903
2020-08-11 10-Q FORM 10-Q 0001437749-20-017514 001-36291 201092400 34 3518578 1
2020-08-11 8-K FORM 8-K 2.02,9.01 0001437749-20-017512 001-36291 201092384 34 256752
2020-08-07 8-K FORM 8-K 1.01,7.01,9.01 0001437749-20-017105 001-36291 201086470 34 349298
2020-08-07 424B5 FORM 424B5 0001437749-20-017103 333-235775 201086420 33 717842
2020-08-05 8-K FORM 8-K 2.02,8.01,9.01 0001437749-20-016685 001-36291 201078111 34 237392
2020-08-05 424B5 FORM 424B5 0001437749-20-016682 333-235775 201078053 33 714131
2020-06-03 8-K FORM 8-K 5.07,8.01 0001437749-20-012348 001-36291 20940406 34 41137
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000055 5955
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000054 5946
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000053 6194
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000052 5957
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000051 9809
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000050 7293
2020-06-02 4 PRIMARY DOCUMENT 0001235802-20-000049 7282
2020-05-13 10-Q FORM 10-Q 0001437749-20-010599 001-36291 20873684 34 3205420 1
2020-05-13 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001437749-20-010597 001-36291 20873664 34 3953689
2020-04-20 DEFA14A FORM DEFA14A 0001437749-20-007998 001-36291 20801254 34 524674
2020-04-20 DEF 14A FORM DEF 14A 0001437749-20-007997 001-36291 20801252 34 2054610
2020-03-23 10-K FORM 10-K 0001437749-20-005906 001-36291 20735265 34 7064815 1
2020-03-23 8-K FORM 8-K 2.02,9.01 0001437749-20-005905 001-36291 20735237 34 230795
2020-02-13 8-K FORM 8-K 1.01,7.01,9.01 0001437749-20-002598 001-36291 20611150 34 332872
2020-02-12 SC 13G diamedica13g.htm 0000935836-20-000089 005-90788 20598586 34 60189
2020-02-11 424B5 FORM 424B5 0001437749-20-002327 333-235775 20598271 33 998118
2020-02-11 8-K FORM 8-K 2.02,8.01,9.01 0001437749-20-002240 001-36291 20593883 34 372349
2020-02-11 424B5 FORM 424B5 0001437749-20-002238 333-235775 20593868 33 999666
2020-01-31 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-000815 005-90788 20565139 34 94419
2020-01-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-01-09 15:30:00 9999999995-20-000060 333-235775 20519351 33 1814
2020-01-07 CORRESP filename1.htm 0001437749-20-000296 32520
2020-01-06 UPLOAD filename1.pdf 0000000000-20-000113 46132
2020-01-03 8-K FORM 8-K 1.01,9.01 0001437749-20-000102 001-36291 20503354 34 139601
2020-01-02 S-3 FORM S-3 0001437749-20-000070 333-235775 20501925 33 395663
2019-11-13 10-Q FORM 10-Q 0001437749-19-022682 001-36291 191214193 34 3589350 1
2019-11-13 8-K FORM 8-K 2.02,9.01 0001437749-19-022681 001-36291 191214163 34 266215
2019-11-05 4 PRIMARY DOCUMENT 0001235802-19-000131 5906
2019-11-05 3 PRIMARY DOCUMENT 0001235802-19-000130 6564
2019-10-30 8-K FORM 8-K 5.02 0001437749-19-020938 001-36291 191180805 34 24793
2019-08-19 4 PRIMARY DOCUMENT 0001235802-19-000108 5147
2019-08-19 4 PRIMARY DOCUMENT 0001235802-19-000107 5335
2019-08-16 4 PRIMARY DOCUMENT 0001235802-19-000106 4541
2019-08-16 4 PRIMARY DOCUMENT 0001235802-19-000105 4812
2019-08-13 10-Q FORM 10-Q 0001437749-19-016595 001-36291 191021750 34 3590521 1
2019-08-13 8-K FORM 8-K 1.02,2.02,9.01 0001437749-19-016566 001-36291 191021011 34 261154
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000067 7152
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000066 5937
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000065 6101
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000064 6169
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000063 6105
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000062 5924
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000061 8622
2019-06-26 4 PRIMARY DOCUMENT 0001235802-19-000060 5932
2019-06-21 8-K FORM 8-K 5.02,9.01 0001437749-19-012427 001-36291 19911481 34 201793
2019-06-19 8-K FORM 8-K 7.01,8.01,9.01 0001437749-19-012278 001-36291 19906113 34 5578630
2019-06-04 8-A12B/A FORM 8-A12B/A 0001437749-19-011316 001-36291 19875271 34 52609
2019-06-04 8-K FORM 8-K 1.01,3.03,5.03,9.01 0001437749-19-011313 001-36291 19875265 34 1022377
2019-05-31 4 PRIMARY DOCUMENT 0001235802-19-000045 5333
2019-05-28 4 PRIMARY DOCUMENT 0001235802-19-000044 4530
2019-05-23 S-8 FORM S-8 0001437749-19-010767 333-231717 19850932 33 113518
2019-05-23 8-K FORM 8-K 5.02,5.07,9.01 0001437749-19-010747 001-36291 19850018 34 271169
2019-05-13 10-Q FORM 10-Q 0001437749-19-009677 001-36291 19819051 34 3202262 1
2019-05-13 8-K FORM 8-K 2.02,9.01 0001437749-19-009676 001-36291 19818998 34 208819
2019-04-29 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-19-003096 005-90788 19776349 34 91514
2019-04-08 DEFA14A FORM DEFA14A 0001437749-19-006694 001-36291 19736321 34 484021
2019-04-08 DEF 14A FORM DEF 14A 0001437749-19-006692 001-36291 19736302 34 2138652
2019-03-29 4 PRIMARY DOCUMENT 0001235802-19-000030 6034
2019-03-20 PRE 14A FORM PRE 14A 0001437749-19-005357 001-36291 19694961 34 2138766
2019-03-19 8-K FORM 8-K 2.02,9.01 0001437749-19-005268 001-36291 19692505 34 198734
2019-03-19 10-K FORM 10-K 0001437749-19-005272 001-36291 19692088 34 6528328 1
2019-02-26 8-K FORM 8-K 8.01 0001437749-19-003322 001-36291 19631670 34 19439
2019-02-01 SC 13G SCHEDULE 13G 0001437749-19-001703 005-90788 19560194 34 59784
2019-01-29 SC 13G SCHEDULE 13G 0001437749-19-001495 005-90788 19549037 34 93656
2019-01-24 SC 13G SCHEDULE 13G 0001437749-19-001263 005-90788 19540475 34 83190
2019-01-09 8-K FORM 8-K 3.01,9.01 0001437749-19-000614 001-36291 19518691 34 47472
2019-01-03 8-K FORM 8-K 7.01,8.01,9.01 0001437749-19-000116 001-36291 19503632 34 55696
2018-12-14 S-8 FORM S-8 0001437749-18-022039 333-228821 181236135 33 134626
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000185 5788
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000184 4537
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000183 4744
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000182 4807
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000181 4741
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000180 4524
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000179 7259
2018-12-11 4 PRIMARY DOCUMENT 0001235802-18-000178 4536
2018-12-11 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001437749-18-021894 001-36291 181228831 34 403681
2018-12-10 424B4 FORM 424B4 0001437749-18-021842 333-228313 181226696 33 3077281
2018-12-07 CT ORDER filename1.pdf 20181206,20181206 9999999997-18-009337 333-228313 181220275 33 108615
2018-12-06 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2018-12-06 17:00:00 9999999995-18-003050 333-228313 181222108 33 1815
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000176 8601
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000175 12154
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000174 16956
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000173 9557
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000172 19458
2018-12-06 3 PRIMARY DOCUMENT 0001235802-18-000171 21851

Latest XBRL company facts

One latest value per concept from companyfacts (203 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 53.96M 2026-11-09 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
dei EntityPublicFloat Entity Public Float USD 95.80M 2025-06-30 2025 FY 10-K 2026-03-30 0001437749-26-010342
ffd NetFeeAmt NetFeeAmt USD 3,197.36 2026-08-10 S-8 2026-08-11 0001437749-26-026864
ffd TtlFeeAmt TtlFeeAmt USD 3,197.36 2026-08-10 S-8 2026-08-11 0001437749-26-026864
ffd TtlOfferingAmt TtlOfferingAmt USD 23.15M 2026-08-10 S-8 2026-08-11 0001437749-26-026864
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-10 S-8 2026-08-11 0001437749-26-026864
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 3.02M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034925
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 509,000 2021-12-31 2021 FY 10-K 2022-03-14 0001437749-22-006163
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 176,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 4.69M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 171,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 171,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -55,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 232.97M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 303,000 2021-07-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001437749-21-026175
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 100,000 2024-04-01 2024-06-30 2025 Q2 10-Q 2025-08-12 0001437749-25-026207
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap Assets Assets USD 36.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AssetsCurrent Assets, Current USD 35.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AssetsNoncurrent Assets, Noncurrent USD 661,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2023-03-31 2023 Q1 10-Q 2023-05-15 0001437749-23-014616
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 5,000 2018-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 18,000 2018-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap Cash Cash USD 16.82M 2018-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 6.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -583,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001437749-20-010599
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 34.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 6.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -8.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 11.86M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 53.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 53.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -31.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 28,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Current USD 250,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 817,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 34.18M 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 40.32M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 3,000 2019-12-31 2020 FY 10-K 2021-03-10 0001437749-21-005541
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 419,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 92,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 42.41M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DeferredTaxLiabilitiesDeferredExpense Deferred Tax Liabilities, Deferred Expense USD 97,000 2018-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 71,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 234,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 166,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 200,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001437749-25-034469
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap Depreciation Depreciation USD 35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 84,000 2017-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.58 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.65 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001437749-22-006163
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.253 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.111 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 10.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 39,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 24,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 7.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -33.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -31.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 381,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -6.88M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-11 0001437749-21-019480
us-gaap IncomeTaxesPaid Income Taxes Paid USD 20,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 2,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001437749-21-026175
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 8.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -74,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -4,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 137,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 515,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 2,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -3.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 372,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -82,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 2,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001437749-21-005541
us-gaap InterestPayableCurrent Interest Payable, Current USD 73,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0001437749-22-026609
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 137,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap InvestmentIncomeAmortizationOfDiscount Investment Income, Amortization of Discount USD 4,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-10 0001437749-21-005541
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 470,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015220
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 506,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.09 2021-12-31 2021 FY 10-K 2022-03-14 0001437749-22-006163
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 159,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 119,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 10,000 2023-12-31 2023 FY 10-K 2024-03-19 0001437749-24-008522
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 10,000 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 10,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 30,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 36.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 40,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap MarketableSecurities Marketable Securities USD 38.00M 2022-03-31 2022 Q1 10-Q 2022-05-04 0001437749-22-010876
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 28.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 1.00M 2025-03-31 2025 Q1 10-Q 2025-05-13 0001437749-25-016488
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 663,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 16.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -26.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -31.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingExpenses Operating Expenses USD 34.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -32.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingLeaseCost Operating Lease, Cost USD 78,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 40,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 130,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 23,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-06 0001437749-26-015220
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap OtherReceivables Other Receivables USD 1,000 2024-12-31 2024 FY 10-K 2025-03-17 0001437749-25-008018
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 8,000 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD -12,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-04 0001437749-20-022537
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 29.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 411,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 94,000 2023-12-31 2023 FY 10-K 2024-03-19 0001437749-24-008522
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 29.90M 2025-07-21 2025 Q2 10-Q 2025-08-12 0001437749-25-026207
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 46.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0001437749-23-008189
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 671,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 607,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 302,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 131,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 25.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -204.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 500,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 446,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001437749-22-026609
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.011 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-19 0001437749-19-005272
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-28 0001437749-23-008189
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 45,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001437749-25-034469
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 52,187 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001437749-22-026609
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.3 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 3.86M 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 801,372 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 2.57 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.06 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4.88M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.63M 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034925
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 3.31 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034925
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 918,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 1.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 2.28 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001437749-26-010342
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.88 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-13 0001437749-24-034925
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 8.03 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001437749-25-034469
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.94 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001437749-22-026609
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.61 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-09 0001437749-22-026609
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 3.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 8.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 4.7 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 3.92 2021-09-26 2022 FY 10-K 2023-03-28 0001437749-23-008189
us-gaap SharesOutstanding Shares, Outstanding shares 26.44M 2021-12-31 2022 FY 10-K 2023-03-28 0001437749-23-008189
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 1.53M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 28.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 7.65M 2021-09-26 2022 FY 10-K 2023-03-28 0001437749-23-008189
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 2,517 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 212,587 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 11.75M 2024-04-01 2024-06-30 2025 Q2 10-Q 2025-08-12 0001437749-25-026207
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 116,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap Supplies Prepaid Supplies USD 317,000 2023-12-31 2023 FY 10-K 2024-03-19 0001437749-24-008522
us-gaap VariableLeaseCost Variable Lease, Cost USD 71,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 84,000 2017-12-31 2019 FY 10-K 2020-03-23 0001437749-20-005906
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 20.77M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001437749-22-006163
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 53.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001437749-26-036602

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →